CXCR6 is expressed on T cells in both T helper type 1 (Th1) inflammation and allergen‐induced Th2 lung inflammation but is only a weak mediator of chemotaxis
Open Access
- 16 April 2007
- journal article
- Published by Wiley in Immunology
- Vol. 121 (4) , 555-564
Abstract
Summary Numerous chemokine receptors are increased in number on T cells in inflamed tissues. Our objective was to examine CXCR6 expression on lymphocytes during immune and inflammatory reactions and its potential for mediating T‐cell recruitment. The cDNA for rat CXCR6 was cloned and monoclonal antibodies (mAbs) to CXCR6 were developed. CXCR6 was present on 4–6% of CD4 and CD8 T cells in blood, normal lymph nodes (LNs) and the spleen, primarily on memory T cells. In vitro antigen re‐stimulation of LN T cells from animals with autoimmune arthritis and experimental autoimmune encephalomyelitis (EAE) increased the proportion of CXCR6+ T cells to 35–50% and anti‐T‐cell receptor (TCR) activation to 60–80%. In vivo, after antigen challenge of LNs there was only a small increase in CXCR6+ T cells on the lymphoblasts in the LNs, and a much higher percentage of T cells were CXCR6+ in virus‐induced peritoneal exudates (∼47%) and in allergen‐induced lung inflammation (33%). Chemotaxis of CXCR6‐expressing inflammatory T cells to CXCL16 was poor, but that to CXCL10 was robust. We conclude that few T cells in normal and antigen‐challenged LNs are CXCR6+, whereas a high proportion of in vitro activated T cells and T cells from inflammatory sites are CXCR6+, but these cells migrate poorly to CXCL16. This suggests that CXCR6 may contribute to T‐cell positioning and activation, rather than recruitment. CXCR6 is also expressed on T cells not only in T helper type 1 (Th1) inflammation (arthritis and EAE) but also, as shown here, in Th2 inflammation, where it is increased after allergen challenge.Keywords
This publication has 49 references indexed in Scilit:
- A transmembrane chemokine, CXC chemokine ligand 16, expressed by lymph node fibroblastic reticular cells has the potential to regulate T cell migration and adhesionInternational Immunology, 2006
- Expression of CXCR6 and its ligand CXCL16 in the lung in health and diseaseClinical & Experimental Allergy, 2005
- CXCR3 is required for migration to dermal inflammation by normal andin vivo activated T cells: differential requirements by CD4 and CD8 memory subsetsEuropean Journal of Immunology, 2005
- Chemokine‐receptor expression on T cells in lung compartments of challenged asthmatic patientsClinical & Experimental Allergy, 2005
- Differential roles of VLA‐4(CD49d/CD29) and LFA‐1(CD11a/CD18) integrins and E‐ and P‐selectin during developing and established active or adoptively transferred adjuvant arthritis in the ratImmunology & Cell Biology, 2003
- Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among Vα24+Vβ11+ NKT cell subsets with distinct cytokine-producing capacityBlood, 2002
- Bonzo/CXCR6 expression defines type 1–polarized T-cell subsets with extralymphoid tissue homing potentialJournal of Clinical Investigation, 2001
- The Biology of Chemokines and their ReceptorsAnnual Review of Immunology, 2000
- 6-C-kine (SLC), a Lymphocyte Adhesion-triggering Chemokine Expressed by High Endothelium, Is an Agonist for the MIP-3β Receptor CCR7Journal of Cell Biology, 1998
- STRL33, A Novel Chemokine Receptor–like Protein, Functions as a Fusion Cofactor for Both Macrophage-tropic and T Cell Line–tropic HIV-1Journal of Experimental Medicine, 1997